Migraine
Pfizerās Nurtec gets thumbs up from NICE for migraine attacks
England’s National Institute of Care and Health Excellence (NICE) has granted approval for Pfizer’s Vydura (rimegepant) as a treatment for ...
Pfizer CEO supports migraine sufferers and urges employers to do the same
Pfizer’s CEO, Dr. Albert Bourla, is championing a disease awareness campaign by leveraging his social media platforms to underscore the ...
Aquipta Gets the Nod for Migraine Prevention in European Adults, courtesy of AbbVie
AbbVie has made a significant stride in the realm of migraine management with the European Commission’s green light for Aquipta ...
Pre-launch KOL conversations may have increased medicine uptake by 1.5 times
Source – Veeva Systems An analysis conducted by Veeva Systems suggests that effective engagement between medical science liaisons (MSLs) and ...
AbbVie Receives Favorable CHMP Opinion for Atogepant as Preventive Treatment for Migraine in Adults
Source – AbbVie AbbVie announced on June 23, 2023, that the Committee for Medicinal Products for Human Use (CHMP) of ...
In a migraine head-to-head matchup, Pfizer’s Nurtec defeats Eli Lilly’s Emgality
Source – PR Newswire In a side-by-side comparison, Emgality did not outperform Pfizer’s Nurtec in preventing episodic migraines, Lilly said ...
Groundbreaking Clinical Trial Confirms Effectiveness of Emgality in Preventing Episodic Migraines
Source: Eli Lilly and Company On June 16, 2023, Eli Lilly and Company released the findings of the CHALLENGE-MIG clinical ...
